跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,199 条关于
“angiotensinogen (AGT)”
全部
11,199
临床试验
8,161
药物
703
机构
361
资讯
1,974
去年
Alnylam's Zilebesiran Receives MHRA Innovation Passport for Hypertension Treatment
2年前
Innovent and SanegeneBio Initiate Phase 1 Trial of IBI3016 for Hypertension
2年前
Alnylam Advances Zilebesiran to Phase 3 Cardiovascular Outcomes Trial Following Positive KARDIA-3 Results
8个月前
Corsera Health Raises $80M Series A as Preventative Cardiovascular siRNA Therapy Enters Clinical Testing
去年
Alnylam Advances Heart Drug Zilebesiran to Phase 3 Trial Despite Mid-Stage Statistical Miss
去年
Biotech Veterans Launch Corsera Health with Annual RNAi Drug to Prevent Cardiovascular Disease
去年
Alnylam's Zilebesiran Advances to Phase III ZENITH Trial for Hypertension Treatment
去年
Roche and Alnylam Advance Zilebesiran to Phase III Cardiovascular Outcomes Trial Following Positive KARDIA-3 Results
18天前
Alnylam Presents New Data at ESC Congress 2026 Reinforcing RNAi-Powered TTR Silencing in ATTR-CM and Hypertension
2个月前
Beyond the Pill: RNA Interference, Aldosterone Synthase Inhibition and Incretins Reshape Hypertension Drug Development
第 1 页,共 198 页
上一页
下一页